1
|
Page S, Rode T, Breitkreutz J, Wagner-Hattler L. Minitablets current use and future opportunities - An APV course on manufacturing, packaging, characterization and use of minitablets. Eur J Pharm Biopharm 2024; 199:114294. [PMID: 38636884 DOI: 10.1016/j.ejpb.2024.114294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Accepted: 04/15/2024] [Indexed: 04/20/2024]
Abstract
Recently, APV organized in collaboration with Fette Compacting GmbH a course on current use and future opportunities of minitablets. The course including a workshop was attended by 30 participants and focused on the manufacturing, packaging, characterization and medical use of minitablets. It took place at the Headquarter of Fette Compacting GmbH in Schwarzenbek. This article provides an overview on the topics presented and discussed during the course.
Collapse
Affiliation(s)
- Susanne Page
- Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Grenzacherstr. 124, CH-4070 Basel, Switzerland.
| | - Timo Rode
- Pharmaceutical Development, Nordmark Pharma GmbH, Pinnauallee 4, 25436 Uetersen, Germany.
| | - Jörg Breitkreutz
- Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-Universität Düsseldorf, Universitätsstraße 1, Geb. 26.22, 40225 Düsseldorf, Germany.
| | - Leonie Wagner-Hattler
- Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Grenzacherstr. 124, CH-4070 Basel, Switzerland.
| |
Collapse
|
2
|
Bogdan C, Hales D, Cornilă A, Casian T, Iovanov R, Tomuță I, Iurian S. Texture analysis – a versatile tool for pharmaceutical evaluation of solid oral dosage forms. Int J Pharm 2023; 638:122916. [PMID: 37019322 DOI: 10.1016/j.ijpharm.2023.122916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 03/25/2023] [Accepted: 03/29/2023] [Indexed: 04/05/2023]
Abstract
In the past few decades, texture analysis (TA) has gained importance as a valuable method for the characterization of solid oral dosage forms. As a result, an increasing number of scientific publications describe the textural methods that evaluate the extremely diverse category of solid pharmaceutical products. Within the current work, the use of texture analysis in the characterization of solid oral dosage forms is summarised with a focus on the evaluation of intermediate and finished oral pharmaceutical products. Several texture methods are reviewed regarding the applications in mechanical characterization, and mucoadhesion testing, but also in estimating the disintegration time and in vivo specific features of oral dosage forms. As there are no pharmacopoeial standards for pharmaceutical products tested through texture analysis, and there are important differences between reported results due to different experimental conditions, the choice of testing protocol and parameters is challenging. Thereby, this work aims to guide the research scientists and quality assurance professionals involved in different stages of drug development into the selection of optimal texture methodologies depending on the product characteristics and quality control needs.
Collapse
Affiliation(s)
- Cătălina Bogdan
- Department of Dermopharmacy and Cosmetics, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 12 I. Creangă Street, 400010 Cluj-Napoca, Romania
| | - Dana Hales
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania.
| | - Andreea Cornilă
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Tibor Casian
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Rareș Iovanov
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Ioan Tomuță
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| | - Sonia Iurian
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 V. Babes Street, 400012 Cluj-Napoca, Romania
| |
Collapse
|
3
|
Zuccari G, Alfei S, Marimpietri D, Iurilli V, Barabino P, Marchitto L. Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics. Pharmaceuticals (Basel) 2022; 15:ph15010108. [PMID: 35056165 PMCID: PMC8779937 DOI: 10.3390/ph15010108] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 01/08/2022] [Accepted: 01/14/2022] [Indexed: 11/16/2022] Open
Abstract
In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at home, or extemporaneous medications are routinely compounded in the hospital pharmacies to treat hospitalized children. Despite considerable efforts by regulatory agencies, the pediatric population is still exposed to questionable and potentially harmful practices. When designing medicines for children, the ability to fine-tune the dosage while ensuring the safety of the ingredients is of paramount importance. For these purposes solid formulations may represent a valid alternative to liquid formulations for their simpler formula and more stability, and, to overcome the problem of swelling ability, mini-tablets could be a practicable option. This review deals with the different approaches that may be applied to develop mini-tablets intended for pediatrics with a focus on the safety of excipients. Alongside the conventional method of compression, 3D printing appeared particularly appealing, as it allows to reduce the number of ingredients and to avoid both the mixing of powders and intermediate steps such as granulation. Therefore, this technique could be well adaptable to the daily galenic preparations of a hospital pharmacy, thus leading to a reduction of the common practice of off-label preparations.
Collapse
Affiliation(s)
- Guendalina Zuccari
- Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy;
- Correspondence: ; Tel.: +39-0103-532-627
| | - Silvana Alfei
- Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy;
| | - Danilo Marimpietri
- Stem Cell Laboratory and Cell Therapy Center, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy;
| | - Valentina Iurilli
- Pharmacy, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy; (V.I.); (P.B.)
| | - Paola Barabino
- Pharmacy, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy; (V.I.); (P.B.)
| | - Leonardo Marchitto
- Department of Sciences for the Quality of Life, University of Bologna, Corso D’Augusto 237, 47921 Rimini, Italy;
| |
Collapse
|
4
|
Brokešová J, Slámová M, Zámostný P, Kuentz M, Koktan J, Krejčík L, Vraníková B, Svačinová P, Šklubalová Z. Mechanistic study of dissolution enhancement by interactive mixtures of chitosan with meloxicam as model. Eur J Pharm Sci 2021; 169:106087. [PMID: 34863871 DOI: 10.1016/j.ejps.2021.106087] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 11/15/2021] [Accepted: 11/27/2021] [Indexed: 12/21/2022]
Abstract
To enhance dissolution rate of meloxicam (MX), a poorly soluble model drug, a natural polysaccharide excipient chitosan (CH) is employed in this work as a carrier to prepare binary interactive mixtures by either mixing or co-milling techniques. The MX-CH mixtures of three different drug loads were characterized for morphological, granulometric, and thermal properties as well as drug crystallinity. The relative dissolution rate of MX was determined in phosphate buffer of pH 6.8 using the USP-4 apparatus; a significant increase in MX dissolution rate was observed for both mixed and co-milled mixtures comparing to the raw drug. Higher dissolution rate of MX was evidently connected to surface activation by mixing or milling, which was pronounced by the higher specific surface energy as detected by inverse gas chromatography. In addition to the particle size reduction, the carrier effect of the CH was confirmed for co-milling by linear regression between the MX maximum relative dissolution rate and the total surface area of the mixture (R2 = 0.863). No MX amorphization or crystalline structure change were detected. The work of adhesion/cohesion ratio of 0.9 supports the existence of preferential adherence of MX to the coarse particles of CH to form stable interactive mixtures.
Collapse
Affiliation(s)
- Jana Brokešová
- Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy, Akademika Heyrovského 1203/8, Hradec Králové 500 05, Czech Republic
| | - Michaela Slámová
- Department of Organic Technology, UCT Prague, Faculty of Chemical Technology, Technická 5, Dejvice, Prague 6 166 28, Czech Republic
| | - Petr Zámostný
- Department of Organic Technology, UCT Prague, Faculty of Chemical Technology, Technická 5, Dejvice, Prague 6 166 28, Czech Republic
| | - Martin Kuentz
- University of Applied Sciences and Arts Northwestern Switzerland, Institute of Pharma Technology, Hofackerstrasse 30, Muttenz CH-4132, Switzerland
| | - Jakub Koktan
- Zentiva, K.S., U Kabelovny 130, Prague 10 102 37, Czech Republic
| | - Lukáš Krejčík
- Zentiva, K.S., U Kabelovny 130, Prague 10 102 37, Czech Republic
| | - Barbora Vraníková
- Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy, Akademika Heyrovského 1203/8, Hradec Králové 500 05, Czech Republic
| | - Petra Svačinová
- Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy, Akademika Heyrovského 1203/8, Hradec Králové 500 05, Czech Republic
| | - Zdenka Šklubalová
- Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy, Akademika Heyrovského 1203/8, Hradec Králové 500 05, Czech Republic.
| |
Collapse
|
5
|
Implementing risk-based quality by design for development and optimization of flavored oral disintegrating mini tablets. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2021.102799] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
6
|
Malallah O, Rashid Z, Li CL, Alqurshi A, Alhanan MA, Forbes B, Royall PG. Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets. AAPS PharmSciTech 2021; 22:219. [PMID: 34401966 PMCID: PMC8367883 DOI: 10.1208/s12249-021-02080-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2021] [Accepted: 06/24/2021] [Indexed: 01/11/2023] Open
Abstract
Measuring tablet disintegration is essential for quality control purposes; however, no established method adequately accounts for the timeframe or small volumes of the medium associated with the dissipation process for fast disintegrating tablets (FDTs) in the mouth. We hypothesised that digital imaging to measure disintegration in a low volume of the medium might discriminate between different types of FTD formulation. A digital image disintegration analysis (DIDA) was designed to measure tablet disintegration in 0.05–0.7 mL of medium. A temperature-controlled black vessel was 3D-printed to match the dimensions of each tablet under investigation. An overhead camera recorded the mean grey value of the tablet as a measure of the percentage of the formulation which remained intact as a function of time. Imodium Instants, Nurofen Meltlets and a developmental freeze-dried pilocarpine formulation were investigated. The imaging approach proved effective in discriminating the disintegration of different tablets (p < 0.05). For example, 10 s after 0.7 mL of a saliva simulant was applied, 2.0 ± 0.3% of the new pilocarpine tablet remained, whereas at the same time point, 22 ± 9% of the Imodium Instants had not undergone disintegration (temperature within the vessel was 37 ± 0.5°C). Nurofen Meltlets were observed to swell and showed a percentage recovery of 120.7 ± 2.4% and 135.0 ± 6.1% when 0.05 mL and 0.7 mL volumes were used, respectively. Thus, the new digital image disintegration analysis, DIDA, reported here effectively evaluated fast disintegrating tablets and has the potential as a quality control method for such formulations.
Collapse
|
7
|
Hejduk A, Czajka S, Lulek J. Impact of co-processed excipient particles solidity and circularity on critical quality attributes of orodispersible minitablets. POWDER TECHNOL 2021. [DOI: 10.1016/j.powtec.2021.03.063] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Hellberg E, Westberg A, Appelblad P, Mattsson S. Evaluation of dissolution techniques for orally disintegrating mini-tablets. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2020.102191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Xu Z, Yoshinaga S, Tsunazawa Y, Tokoro C. Numerical investigation of segregation behavior of multi-sized particles during pharmaceutical mini-tablet die filling. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2020.102301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
10
|
Mitra B, Thool P, Meruva S, Aycinena JA, Li J, Patel J, Patel K, Agarwal A, Karki S, Bowen W. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing. Int J Pharm 2020; 574:118905. [DOI: 10.1016/j.ijpharm.2019.118905] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2019] [Revised: 11/20/2019] [Accepted: 11/23/2019] [Indexed: 11/15/2022]
|
11
|
Alsulays BB, Fayed MH, Alalaiwe A, Alshahrani SM, Alshetaili AS, Alshehri SM, Alanazi FK. Mixing of low-dose cohesive drug and overcoming of pre-blending step using a new gentle-wing high-shear mixer granulator. Drug Dev Ind Pharm 2018; 44:1520-1527. [PMID: 29718720 DOI: 10.1080/03639045.2018.1472278] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
The objective of this study was to examine the influence of drug amount and mixing time on the homogeneity and content uniformity of a low-dose drug formulation during the dry mixing step using a new gentle-wing high-shear mixer. Moreover, the study investigated the influence of drug incorporation mode on the content uniformity of tablets manufactured by different methods. Albuterol sulfate was selected as a model drug and was blended with the other excipients at two different levels, 1% w/w and 5% w/w at impeller speed of 300 rpm and chopper speed of 3000 rpm for 30 min. Utilizing a 1 ml unit side-sampling thief probe, triplicate samples were taken from nine different positions in the mixer bowl at selected time points. Two methods were used for manufacturing of tablets, direct compression and wet granulation. The produced tablets were sampled at the beginning, middle, and end of the compression cycle. An analysis of variance analysis indicated the significant effect (p < .05) of drug amount on the content uniformity of the powder blend and the corresponding tablets. For 1% w/w and 5% w/w formulations, incorporation of the drug in the granulating fluid provided tablets with excellent content uniformity and very low relative standard deviation (∼0.61%) during the whole tableting cycle compared to direct compression and granulation method with dry incorporation mode of the drug. Overall, gentle-wing mixer is a good candidate for mixing of low-dose cohesive drug and provides tablets with acceptable content uniformity with no need for pre-blending step.
Collapse
Affiliation(s)
- Bader B Alsulays
- a Department of Pharmaceutics, College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-kharj , Saudi Arabia
| | - Mohamed H Fayed
- a Department of Pharmaceutics, College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-kharj , Saudi Arabia.,b Department of Pharmaceutics, Kayyali Chair for Pharmaceutical Industries, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia
| | - Ahmed Alalaiwe
- a Department of Pharmaceutics, College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-kharj , Saudi Arabia
| | - Saad M Alshahrani
- a Department of Pharmaceutics, College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-kharj , Saudi Arabia
| | - Abdullah S Alshetaili
- a Department of Pharmaceutics, College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-kharj , Saudi Arabia
| | - Sultan M Alshehri
- c Department of Pharmaceutics, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia
| | - Fars K Alanazi
- b Department of Pharmaceutics, Kayyali Chair for Pharmaceutical Industries, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia
| |
Collapse
|
12
|
Thabet Y, Slavkova M, Breitkreutz J. 10 years EU regulation of pediatric medicines – impact on cardiovascular drug formulations. Expert Opin Drug Deliv 2017; 15:261-270. [DOI: 10.1080/17425247.2018.1420054] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Yasmin Thabet
- Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Duesseldorf, Germany
| | - Marta Slavkova
- Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Duesseldorf, Germany
- Faculty of Pharmacy, Medical University, Sofia, Bulgaria
| | - Jörg Breitkreutz
- Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Duesseldorf, Germany
| |
Collapse
|
13
|
Mitra B, Chang J, Wu SJ, Wolfe CN, Ternik RL, Gunter TZ, Victor MC. Feasibility of mini-tablets as a flexible drug delivery tool. Int J Pharm 2017; 525:149-159. [PMID: 28432019 DOI: 10.1016/j.ijpharm.2017.04.037] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 03/27/2017] [Accepted: 04/17/2017] [Indexed: 10/19/2022]
Abstract
Mini-tablets have potential applications as a flexible drug delivery tool in addition to their generally perceived use as multi-particulates. That is, mini-tablets could provide flexibility in dose finding studies and/or allow for combination therapies in the clinic. Moreover, mini-tablets with well controlled quality attributes could be a prudent choice for administering solid dosage forms as a single unit or composite of multiple mini-tablets in patient populations with swallowing difficulties (e.g., pediatric and geriatric populations). This work demonstrated drug substance particle size and concentration ranges that achieve acceptable mini-tablet quality attributes for use as a single or composite dosage unit. Immediate release and orally disintegrating mini-tablet formulations with 30μm to 350μm (particle size d90) acetaminophen and Compap™ L (90% acetaminophen) at concentrations equivalent to 6.7% and 26.7% acetaminophen were evaluated. Mini-tablets achieved acceptable weight variability, tensile strength, friability, and disintegration time at a reasonable solid fraction for each formulation. The content uniformity was acceptable for mini-tablets of 6.7% formulations with ≤170μm drug substance, mini-tablets of all 26.7% formulations, and composite dosage units containing five or more mini-tablets of any formulation. Results supported the manufacturing feasibility of quality mini-tablets, and their applicability as a flexible drug delivery tool.
Collapse
Affiliation(s)
- Biplob Mitra
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA; Drug Product Development, Celgene Corporation, Summit, NJ, USA.
| | - Jessica Chang
- College of Pharmacy, Purdue university, West Lafayette, IN, USA
| | - Sy-Juen Wu
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA
| | - Chad N Wolfe
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA
| | - Robert L Ternik
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA
| | - Thomas Z Gunter
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA
| | - Michael C Victor
- Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA
| |
Collapse
|